Logistics and supply chain zone introduced at ICSE 2011

Shipping options must not only be temperature controlled and protect the integrity of the ingredients, but also reliable and time sensitive

A new Logistics and Supply Chain Zone is to be introduced at ICSE 2011, an event dedicated to pharmaceutical contract services and outsourcing. ICSE will take place from 25 – 27 October 2011 at the Messe Frankfurt, Germany and is part of the world's leading platform of pharmaceutical events, including CPhI Worldwide for pharmaceutical ingredients, P-MEC Europe for pharmaceutical machinery and equipment and InnoPack for pharmaceutical packaging solutions.

Introduced in response to attendee audits conducted at previous events, the new zone will cover logistics, cold transport and supply chain solutions for the pharmaceutical industry. The 2010 events audit showed a total of 1,159 attendees with a specific interest in the logistics and supply chain sector. Of these visitors, 577 attended for logistics resources, 220 for supply chain resources and 362 indicated that their primary interest was pharmaceutical specific logistic and supply chain resources.

The zone will not only provide a meeting place for the industry, with the combined events attracting more than 28,000 attendees annually, but will also address concerns that are at the forefront in the pharma industry such as safe global transportation solutions for ingredients.

‘Beyond being complementary to the focuses of the ICSE event, the new Logistics and Supply Chain Zone also has great synergy with Innopack, which features RFID, Track and Trace, anticounterfeiting and general packaging solutions, and P-MEC, which will host companies that have transportation requirements for pharma machinery and equipment,’ noted Haf Cennydd, Global Brand Director ICSE, P-MEC, and InnoPack.

She added, ‘Moreover, CPhI exhibitors include many large multinationals with requirements for global supply chain logistic solutions which also makes them attractive potential customers for logistics and supply chain companies.’

In 2011, ICSE will be partnered with BioPh, which showcases the biopharma sector, and will offer new zoning to facilitate face-to-face interaction between buyers and sellers of contract services and outsourcing solutions for the pharmaceutical and biopharmaceutical markets. The event, now in its eleventh year, hosts contract research organisations (CROs) and contract manufacturing organisations (CMOs) from all over the world and offers a current view of industry trends in a rapidly expanding global market. Last year, ICSE saw a 24% increase from 2009 exhibitor numbers and due to this exceptional growth ICSE will be located in two halls for 2011.

‘The pharmaceutical industry has seen a lot of change in the past five years. As we move forward and the market stabilises, an increasing focus is being placed on the quality and ability to validate raw materials that are purchased globally,’ Cennydd said.

‘In addition to these considerations, companies have to examine shipping options that are not only temperature controlled and protect the integrity of the ingredients, but are also reliable and time sensitive. The Logistics and Supply Chain Zone offers visitors a dedicated zone for these resources which are an increasingly important within the (bio) pharmaceutical sector.’

Companies